Immobilization of Escherichia coli JM103[pUC8] in κ‐Carrageenan Coupled with Recombinant Protein Release by in Situ Cell Membrane Permeabilization

Immobilization of Escherichia coli JM103[pUC8] was carried out with κ‐carrageenan as the support matrix. Substantial natural excretion of β‐lactamase, attributable to the less intact membrane of plasmid‐harboring cells, was observed in immobilized cell cultures. Nevertheless, a significant portion of the β‐lactamase produced was retained in the cells. As compared to suspension cultures, much higher β‐lactamase activities, especially in the extracellular liquid, and much longer retention of plasmid‐bearing cells (improved plasmid stability) were observed in immobilized cell cultures. Further enhancement in excretion of the recombinant protein (β‐lactamase) was achieved by permeabilization of cell membrane by periodic exposure of the immobilized cell cultures to ethylenediaminetetraacetic acid (EDTA). While the presence of EDTA led to some suppression of cell growth in suspension cultures, cell growth in gel beads was not affected by EDTA to the same extent, possibly due to lesser exposure of immobilized cells to EDTA. Exposure of immobilized cell cultures to EDTA presumably inhibited plasmid replication and led in turn to diversion of cellular resources for the support of expression of plasmid genes. Indeed, treatment of the immobilized cell cultures with EDTA resulted in increased production of β‐lactamase when compared to the enzyme production in EDTA‐free cultures. More frequent addition of EDTA increased the period of retention of plasmid‐bearing cells in these cultures but did not have any noticeable adverse effect on synthesis of β‐lactamase. Improvement in plasmid stability in EDTA‐treated immobilized cell cultures was ascribed to the reduction in the growth rate differential between plasmid‐free and plasmid‐bearing cells, since plasmid‐free cells were subject to more reduction in specific growth rate than were plasmid‐bearing cells.

[1]  S. J. Parulekar,et al.  Characterization of κ‐Carrageenan Gels Used for Immobilization of Bacillus firmus , 1991, Biotechnology progress.

[2]  S. J. Parulekar,et al.  Recombinant protein excretion in Escherichia coli JM103[pUC8]: Effects of plasmid content, ethylenediaminetetraacetate, and phenethyl alcohol on cell membrane permeability , 1991, Biotechnology and bioengineering.

[3]  S. J. Parulekar,et al.  Recombinant protein synthesis and plasmid instability in continuous cultures of Escherichia coli JM103 harboring a high copy number plasmid , 1991, Biotechnology and bioengineering.

[4]  S. J. Parulekar,et al.  Effects of Culture Conditions on Plasmid Stability and Production of a Plasmid‐encoded Protein in Batch and Continuous Cultures of Escherichia coli JM103[pUC8] a , 1990, Annals of the New York Academy of Sciences.

[5]  K. San,et al.  Dynamics of plasmid maintenance in a CSTR upon square‐wave perturbations in the dilution rate , 1989, Biotechnology and bioengineering.

[6]  C. Robertson,et al.  Autoradiographic determination of mass‐transfer limitations in immobilized cell reactors , 1989, Biotechnology and bioengineering.

[7]  S. Sayadi,et al.  Effect of environmental growth conditions on plasmid stability, plasmid copy number, and catechol 2,3‐dioxygenase activity in free and immobilized Escherichia coli cells , 1989, Biotechnology and bioengineering.

[8]  G. Georgiou,et al.  Release of periplasmic enzymes and other physiological effects of β‐lactamase overproduction in Escherichia coli , 1988, Biotechnology and bioengineering.

[9]  George Georgiou,et al.  Optimizing the production of recombinant proteins in microorganisms , 1988 .

[10]  G. A. Bowden,et al.  The Effect of Sugars on β‐Lactamase Aggregation in Escherichia coli , 1988 .

[11]  Sun Bok Lee,et al.  Performance of recombinant fermentation and evaluation of gene expression efficiency for gene product in two‐stage continuous culture system , 1988, Biotechnology and bioengineering.

[12]  G. Lyberatos,et al.  Effect of cycling on the stability of plasmid‐bearing microorganisms in continuous culture , 1988, Biotechnology and bioengineering.

[13]  G. Chotani,et al.  Analysis of Bioreactors Containing Immobilized Recombinant Cells , 1987, Annals of the New York Academy of Sciences.

[14]  W. Weigand,et al.  Effects of recombinant plasmid size on cellular processes in Escherichia coli. , 1987, Plasmid.

[15]  J E Bailey,et al.  Simulations of host–plasmid interactions in Escherichia coli: Copy number, promoter strength, and ribosome binding site strength effects on metabolic activity and plasmid gene expression , 1987, Biotechnology and bioengineering.

[16]  M L Shuler,et al.  Localization of inclusion bodies in Escherichia coli overproducing beta-lactamase or alkaline phosphatase , 1986, Applied and environmental microbiology.

[17]  P. Dhulster,et al.  Plasmid inheritability and biomass production: comparison between free and immobilized cell cultures of Escherichia coli BZ18(pTG201) without selection pressure , 1986, Journal of bacteriology.

[18]  J. Bailey,et al.  Effects of recombinant plasmid content on growth properties and cloned gene product formation in Escherichia coli , 1985, Biotechnology and bioengineering.

[19]  S. Bron,et al.  Segregational instability of pUB110-derived recombinant plasmids in Bacillus subtilis. , 1985, Plasmid.

[20]  M L Shuler,et al.  Continuous Immobilized Recombinant Protein Production from E. coli Capable of Selective Protein Excretion: A Feasibility Study , 1985, Biotechnology progress.

[21]  R. Siegel,et al.  Kinetic study of instability of recombinant plasmid pPLc23trpAl in E. coli using two‐stage continuous culture system , 1985, Biotechnology and bioengineering.

[22]  D. Sherratt,et al.  Multimerization of high copy number plasmids causes instability: Cole 1 encodes a determinant essential for plasmid monomerization and stability , 1984, Cell.

[23]  T. Arakawa,et al.  Stabilization of protein structure by sugars. , 1982, Biochemistry.

[24]  J. Vieira,et al.  The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. , 1982, Gene.

[25]  T. Imanaka,et al.  A PERSPECTIVE ON THE APPLICATION OF GENETIC ENGINEERING: STABILITY OF RECOMBINANT PLASMID , 1981, Annals of the New York Academy of Sciences.

[26]  H. C. Wu,et al.  Physiological characterization of an Escherichia coli mutant altered in the structure of murein lipoprotein , 1978, Journal of bacteriology.

[27]  K. Nordström,et al.  Colicin Tolerance Induced by Ampicillin or Mutation to Ampicillin Resistance in a Strain of Escherichia coli K-12 , 1971, Journal of bacteriology.

[28]  L. Leive,et al.  Release of lipopolysaccharide in Escherichia coli resistant to the permeability increase induced by ethylenediaminetetraacetate. , 1970, The Journal of biological chemistry.

[29]  L. Leive Studies on the permeability change produced in coliform bacteria by ethylenediaminetetraacetate. , 1968, The Journal of biological chemistry.

[30]  H. Neu,et al.  Release of Surface Enzymes in Enterobacteriaceae by Osmotic Shock , 1967, Journal of bacteriology.

[31]  Daniel I. C. Wang Biotechnology : status and perspectives , 1988 .

[32]  T. Imanaka Application of recombinant DNA technology to the production of useful biomaterials. , 1986, Advances in biochemical engineering/biotechnology.

[33]  Channing R. Robertson,et al.  The immobilization of whole cells: Engineering principles , 1985 .

[34]  D. Oliver Protein secretion in Escherichia coli. , 1985, Annual review of microbiology.

[35]  J. Messing New M13 vectors for cloning. , 1983, Methods in enzymology.

[36]  G. Lebek,et al.  Generation time-prolonging R plasmids: correlation between increases in the generation time of Escherichia coli caused by R plasmids and their molecular size. , 1980, Plasmid.

[37]  C. A. Thomas,et al.  Molecular cloning. , 1977, Advances in pathobiology.

[38]  Jeffrey H. Miller Experiments in molecular genetics , 1972 .

[39]  C. O'callaghan,et al.  Effects of beta-lactamase from gram-negative organisms on cephalosporins and penicillins. , 1968, Antimicrobial agents and chemotherapy.